Clinical Trial Update: Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of Triapine and Gemcitabine hydrochloride in gallbladder cancer across multiple stages; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Triapine (Triapine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Gallbladder Cancer, Stage IIIA Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-09-28